The store will not work correctly when cookies are disabled.
filorexant - ≥98%, high purity , Orexin receptor antagonist, CAS No.1088991-73-4, Orexin receptor antagonist
Basic Description
| Synonyms | AC-35933 | CCG-100657 | GTPL4460 | Methanone, ((2R,5R)-5-(((5-fluoro-2-pyridinyl)oxy)methyl)-2-methyl-1-piperidinyl)(5-methyl-2-(2-pyrimidinyl)phenyl)- | BDBM104692 | NT5 | DTXSID50148764 | CS-4437 | NCGC00484077-01 | Tox21_113634 | AS-82282 | [(2~{R},5~{ |
|---|
| Specifications & Purity | Moligand™, ≥98% |
|---|
| Storage Temp | Store at -20°C |
|---|
| Shipped In | Ice chest + Ice pads |
|---|
| Grade | Moligand™ |
|---|
| Action Type | ANTAGONIST |
|---|
| Mechanism of action | Orexin receptor antagonist |
|---|
| Product Description | Filorexant (MK-6096) is an orally bioavailable effective and selective reversible antagonist of OX1 and OX2 receptor with (Ki <3 nM).
|
|---|
Associated Targets(Human)
Associated Targets(non-human)
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Names and Identifiers
| IUPAC Name | [(2R,5R)-5-[(5-fluoropyridin-2-yl)oxymethyl]-2-methylpiperidin-1-yl]-(5-methyl-2-pyrimidin-2-ylphenyl)methanone |
|---|
| INCHI | InChI=1S/C24H25FN4O2/c1-16-4-8-20(23-26-10-3-11-27-23)21(12-16)24(30)29-14-18(6-5-17(29)2)15-31-22-9-7-19(25)13-28-22/h3-4,7-13,17-18H,5-6,14-15H2,1-2H3/t17-,18-/m1/s1 |
|---|
| InChi Key | NPFDWHQSDBWQLH-QZTJIDSGSA-N |
|---|
| Canonical SMILES | CC1CCC(CN1C(=O)C2=C(C=CC(=C2)C)C3=NC=CC=N3)COC4=NC=C(C=C4)F |
|---|
| Isomeric SMILES | C[C@@H]1CC[C@H](CN1C(=O)C2=C(C=CC(=C2)C)C3=NC=CC=N3)COC4=NC=C(C=C4)F |
|---|
| Alternate CAS | 1088991-73-4 |
|---|
| PubChem CID | 25128145 |
|---|
| MeSH Entry Terms | (5-((5-fluoropyridin-2-yloxy)methyl)-2-methylpiperidin-1-yl)(5-methyl-2-(pyrimidin-2-yl)phenyl)methanone;filorexant;MK-6096 |
|---|
| Molecular Weight | 420.48 |
|---|
Chemical and Physical Properties
| Solubility | DMSO: 100 mg/mL (237.82 mM), Sonification is recommended. |
|---|
References
| 1. Winrow CJ, Gotter AL, Cox CD, Tannenbaum PL, Garson SL, Doran SM, Breslin MJ, Schreier JD, Fox SV, Harrell CM et al.. (2012) Pharmacological characterization of MK-6096 - A dual orexin receptor antagonist for insomnia.. Neuropharmacology, 62 (2): (978-87). [PMID:22019562] |
Solution Calculators
Molarity Calculator
Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.
Reconstitution Calculator
I2412358